IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Opportunity Management V, LLC

Q2 2022 Holdings

Filed 2022-08-12 | 9 holdings | $4.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Compass Therapeutics, Inc.(CMPX)COM20454B104$4.1M1,554,25099.1%
Pardes Biosciences IncCOM69945Q105$16.0K5,227,3070.4%
Theseus Pharmaceuticals, Inc.COM88369M101$5.3K959,2750.1%
Gemini Therapeutics, Inc.COM36870G105$4.1K2,435,1250.1%
Kinnate Biopharma Inc.COM49705R105$3.7K291,6670.1%
Adicet Bio, Inc.(TORCEUR)COM007002108$2.5K170,0000.1%
Quantum-Si Incorporated(QSI)COM CL A74765K105$1.5K633,6260.0%
Hims & Hers Health, Inc.(HIMS)COM CL A433000106$1.4K306,4310.0%
Enanta Pharmaceuticals, Inc.(ENTA)COM29251M106$1.1K22,7500.0%